miR-212 exerts oncogenic effects in gastric cancer by suppressing RBP2 expression and increasing the expression of P21 CIP1 and P27 kip1 to arrest the cell cycle and inhibit cell colony formation (100). The gene discussed is CDKN1A; the disease is gastric cancer.